Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): Rationale and study design

Keyphrases

• Deep Vein Thrombosis 100%
• Warfarin 100%
• Informatics 100%
• International Normalized Ratio 66%
• Acute Venous Thromboembolism 66%
• Surgical Procedures 33%
• Perioperative Risk 33%
• Adverse Events 33%
• Pharmacogenetics 33%
• Randomized Controlled Trial 33%
• Orthopedics 33%
• Total Knee Replacement 33%
• Orthopaedic Patients 33%
• Warfarin Sodium 33%
• Dose Variability 33%
• Venous Thromboembolism 33%
• Major Haemorrhage 33%
• Total Hip Replacement 33%
• Narrow Therapeutic Window 33%
• Dosing Strategy 33%
• Hemorrhage 33%
• Warfarin Dosing 33%
• Two-factor Designs 33%
• Individual Dose 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Warfarin 100%
• Deep Vein Thrombosis 100%
• Venous Thromboembolism 40%
• Adverse Event 20%
• Randomized Controlled Trial 20%
• Pharmacogenetics 20%
• Therapeutic Window 20%